Dr. Ovsyannikova, Professor of Medicine, is the Director of Laboratory-based studies for the Mayo Clinic Vaccine Research Group in Rochester, MN. She has published over 190 scientific manuscripts and 15 books/book chapters. She has participated in more than 150 scientific exhibits and presentations at national and international societies.
Dr. Ovsyannikova’s research areas of great interest include: 1) studies of the genetics of innate and adaptive immune responses to viral and bacterial vaccines, including measles, mumps, rubella, vaccinia, influenza and anthrax; 2) areas of vaccine-preventable infectious diseases, particularly the application of mass spectrometry used to develop peptide-based vaccines against smallpox, measles, influenza, Zika and agents of bioterrorism; 3) gene polymorphisms and predictors of vaccine immune response, icluding adverse events, viral antigen processing and presentation; 4) systems biology high-dimensional studies utilizing platforms such as gene expression microarrays, DNA methylation arrays and next generation sequencing (mRNA-Seq, miRNA-Seq).